Statistics for Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer
Total visits
| views | |
|---|---|
| Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer | 0 |
Total visits per month
| views | |
|---|---|
| November 2023 | 0 |
| December 2023 | 0 |
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
File Visits
| views | |
|---|---|
| sungpil_fda_2021.pdf | 24 |